Cysticercosis: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*Parasitic infection caused by larval stage of ''Taenia solium'' (pork tapeworm)
[[File:pic cyst.png|thumbnail]]
*Parasitic infection caused by larval stage of ''Taenia solium'' (pork tapeworm)<ref>CDC Cysticercosis http://www.cdc.gov/parasites/cysticercosis/</ref>
*Occurs when humans (definitive host) ingest poorly cooked pig (intermediate host) that is infected with larvae (cysticerci)
*Occurs when humans (definitive host) ingest poorly cooked pig (intermediate host) that is infected with larvae (cysticerci)
*Estimated 50-100 million people infected worldwide
*Estimated 50-100 million people infected worldwide
Line 13: Line 14:
**Muscle: asymptomatic or sometimes painful due to surrounding inflammation
**Muscle: asymptomatic or sometimes painful due to surrounding inflammation
**Cardiac cysts are rare: arrhythmias/conduction abnormalities
**Cardiac cysts are rare: arrhythmias/conduction abnormalities
*Neurocysticercosis (NCC)
*Neurocysticercosis (NCC)<ref>Wallin MT. et al. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. Nov 9 2004;63(9):1559-64</ref>
**Parenchymal NCC  
**Parenchymal NCC  
***Most common presentation of NCC  
***Most common presentation of NCC  
Line 33: Line 34:
==Workup==
==Workup==
*Imaging is usually best
*Imaging is usually best
**CT head (calcifications/edema); MRI (cysts +/- scolex, edema)
**CT head (calcifications/edema); MRI (cysts +/- scolex, edema)<ref>García HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003;87(1):71-8</ref>
**X-rays or CT for extraneural cysticercosis
**X-rays or CT for extraneural cysticercosis
*EITB assay for anticysticercal antibody
*EITB assay for anticysticercal antibody
Line 51: Line 52:
**If just one lesion or cosmetic issue, surgical excision
**If just one lesion or cosmetic issue, surgical excision
**Otherwise: NSAIDs
**Otherwise: NSAIDs
*Symptomatic NCC
===Symptomatic NCC===
**Anticonvulsants (keppra, dilantin, newer agents)
*Anticonvulsants (keppra, dilantin, newer agents)
**Antihelminthic therapy and steroids  
*Antihelminthic therapy and steroids  
***Treat if edema, mass effect, or vasculitis
**Treat if edema, mass effect, or vasculitis
***Don’t treat if old calcifications on CT without edema
**Don’t treat if old calcifications on CT without edema
***Before starting these meds, need to check for:
**Before starting these meds, need to check for:
****positive PPD  
***positive PPD  
****co-infection w/ Strongyloides (steroids can cause to disseminate)
***co-infection w/ Strongyloides (steroids can cause to disseminate)
****ocular involvement (inflammation associated with dying organisms can result in vision loss by causing chorioretinitis, retinal detachment, or vasculitis)  
***ocular involvement (inflammation associated with dying organisms can result in vision loss by causing chorioretinitis, retinal detachment, or vasculitis)  
***Pts started on therapy get admitted to watch for any adverse events initially
**Pts started on therapy get admitted to watch for any adverse events initially
***First line: Albendazole 15mg/kg/day divided in 2 doses
===Antiparasite Medications===
***Second line: Praziquantel: 50-100mg/kg/day divided in 3 doses
*Albendazole
*15mg/kg/day divided in 2 doses<ref>Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.</ref>
**First line therapy
*'''Praziquantel'''
**Second line therapy
**50-100mg/kg/day divided in 3 doses <ref>Sotelo J. et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. May 1988;45(5):532-4</ref>
***Steroids:  Prednisone 1mg/kg/day or Dexamethasone 0.1mg/kg/day
***Steroids:  Prednisone 1mg/kg/day or Dexamethasone 0.1mg/kg/day
**If hydrocephalus present, CSF diversion with ventriculostomy or VP shunt by Neurosurgery and/or surgical resection of cysts.
**If hydrocephalus present, CSF diversion with ventriculostomy or VP shunt by Neurosurgery and/or surgical resection of cysts.
*Ocular  
===Ocular===
**Intra-ocular:  surgery  
*Intra-ocular:  surgery <ref>Sharma T. et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003;110(5):996-1004</ref>
**Extra-ocular muscle involvement: albendazole and steroids
*Extra-ocular muscle involvement: albendazole and steroids<ref>Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit. Dec 2004;23(4):255-62</ref>
*Spinal intramedullary: possibly surgery
*Spinal intramedullary: possibly surgery


Line 75: Line 81:
*ICU for uncontrolled seizures, AMS, increased ICP  
*ICU for uncontrolled seizures, AMS, increased ICP  


                                                                    [[File:pic cyst.png|thumbnail]]
                                                                   


==Sources==
==Sources==
*Mansur MM and Cunha BA.  “Cysticercosis.”  ''www.emedicine.medscape.com.''  Oct 2012.
<references/>
*Khosla, A and Smirniotopoulos.  “CNS Imaging in Cysticercosis.”  ''www.emedicine.medscape.com.''  Oct 2012.
*White AC, Weller PF and Baron EL.  “Treatment of cysticercosis.”  ''www.uptodate.com.''  Jul 2014.
*White AC, Weller PF and Baron EL.  “Clinical manifestations and diagnosis of cysticercosis.”  ''www.uptodate.com.''  Jul 2014.
*Rosen’s Emergency Medicine

Revision as of 00:22, 1 September 2014

Background

Pic cyst.png
  • Parasitic infection caused by larval stage of Taenia solium (pork tapeworm)[1]
  • Occurs when humans (definitive host) ingest poorly cooked pig (intermediate host) that is infected with larvae (cysticerci)
  • Estimated 50-100 million people infected worldwide
    • 1,000 new cases in US per year, mostly in immigrants from Latin America but also seen in those from Asia or Africa
  • More than 80% of those affected are asymptomatic
  • Cysts can reside anywhere in body

Clinical Features

Divided into extraneural cysticercosis (outside CNS) and neurocysticercosis (which can be parenchymal, extraparenchymal or both)

  • Extraneural cysticercosis
    • Subcutaneous tissue: nodules that are not cosmetically pleasing, but usually asymptomatic
    • Muscle: asymptomatic or sometimes painful due to surrounding inflammation
    • Cardiac cysts are rare: arrhythmias/conduction abnormalities
  • Neurocysticercosis (NCC)[2]
    • Parenchymal NCC
      • Most common presentation of NCC
      • Most cases are asymptomatic and discovered incidentally after resolution of infection (see image below)
      • Those with symptoms usually present with seizures (focal or generalized)
      • Focal neurologic deficit
    • Extraparenchymal NCC: more often present with headaches, vomiting, hydrocephalus
      • Intraventricular cysts: can get lodged in ventricular outflow tracts and cause obstructive hydrocephalus and increased ICP causing nausea, vomiting, AMS, papilledema
      • Subarachnoid cysts: can cause inflammatory response leading to arachnoiditis which may result in hydrocephalus, meningitis, stroke, and vasculitis
      • Ocular (1-3% of cases): diplopia if EOM involvement, vision loss or pain if intra-ocular
      • Spinal (1% of cases): radicular pain, paresthesias, cauda equina symptoms

Differential Diagnosis

  • Brain abscess
  • Vasculitis
  • Tuberculomas or Mycotic granulomas
  • Primary brain tumors or metastases

Workup

  • Imaging is usually best
    • CT head (calcifications/edema); MRI (cysts +/- scolex, edema)[3]
    • X-rays or CT for extraneural cysticercosis
  • EITB assay for anticysticercal antibody
    • Serum (more sensitive) or CSF studies (less common)
  • Labs
    • Usually not helpful
    • Eosinophilia not seen unless cyst is leaking/ruptured
  • Depending on presentation, involvement of the following services may be needed:
    • Neurology: for seizures refractory to meds
    • Neurosurgery: hydrocephalus, mass effect, herniation
    • Infectious disease: if starting antiparasitic therapy
    • Ophthalmology: if suspect ocular involvement or if starting antibiotics and need to confirm no ocular involvement

Management

  • Asymptomatic: observation
  • Subcutaneous or intramuscular: typically observation
    • If just one lesion or cosmetic issue, surgical excision
    • Otherwise: NSAIDs

Symptomatic NCC

  • Anticonvulsants (keppra, dilantin, newer agents)
  • Antihelminthic therapy and steroids
    • Treat if edema, mass effect, or vasculitis
    • Don’t treat if old calcifications on CT without edema
    • Before starting these meds, need to check for:
      • positive PPD
      • co-infection w/ Strongyloides (steroids can cause to disseminate)
      • ocular involvement (inflammation associated with dying organisms can result in vision loss by causing chorioretinitis, retinal detachment, or vasculitis)
    • Pts started on therapy get admitted to watch for any adverse events initially

Antiparasite Medications

  • Albendazole
  • 15mg/kg/day divided in 2 doses[4]
    • First line therapy
  • Praziquantel
    • Second line therapy
    • 50-100mg/kg/day divided in 3 doses [5]
      • Steroids: Prednisone 1mg/kg/day or Dexamethasone 0.1mg/kg/day
    • If hydrocephalus present, CSF diversion with ventriculostomy or VP shunt by Neurosurgery and/or surgical resection of cysts.

Ocular

  • Intra-ocular: surgery [6]
  • Extra-ocular muscle involvement: albendazole and steroids[7]
  • Spinal intramedullary: possibly surgery

Disposition

  • Home if asymptomatic or no complications w/ good pain control
  • Admit if starting antihelminthic therapy for further testing as listed above and to monitor initial side effects of drug therapy
  • ICU for uncontrolled seizures, AMS, increased ICP


Sources

  1. CDC Cysticercosis http://www.cdc.gov/parasites/cysticercosis/
  2. Wallin MT. et al. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. Nov 9 2004;63(9):1559-64
  3. García HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003;87(1):71-8
  4. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.
  5. Sotelo J. et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. May 1988;45(5):532-4
  6. Sharma T. et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003;110(5):996-1004
  7. Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit. Dec 2004;23(4):255-62